{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Interactive ePatient Case: Spinal Muscular Atrophy (SMA) in Adults
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Can you recognize the signs that would make you suspect spinal muscular atrophy (SMA), are you familiar with the recommended diagnostic process, and do you know how to develop individualized care plans for treating your adult patients with SMA? This 30-minute learning activity, featuring an interactive patient case, was developed with a leading expert in the field of SMA, Dr Emma Ciafaloni. It will provide practical guidance on how to create treatment plans that include multidisciplinary care, as well as how to choose and use standardized assessment tools to improve practices in your clinic. Target Audience This activity has been designed to meet the educational needs of neurologists, pediatric neurologists, neuromuscular disease specialists, orthopedists, pulmonologists, physical therapists, and nurses involved in the management of patients with SMA.
Learning Objectives
After completing this continuing education activity you will be able to:
- Outline and recognize signs of SMA and diagnose accurately
- Develop individualized care plans for treatment and multidisciplinary management of adult patients with SMA
- Select and apply standardized assessment tools for clinical changes
- Evaluate real-world experience on current treatments for adult patients with SMA
Disclosures
Dr. Ciafaloni has disclosed that she was/is on the speaker bureau for Biogen; was/is a consultant/advisor for AveXis, Inc., Biogen, Pfizer, Ra Pharma�, Santhera, Sarepta Therapeutics, Inc., and Wave Life Sciences; was/is a grant/research support recipient for Orphazyme, Santhera, and Sarepta Therapeutics, Inc.
Non-Faculty All planners in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interest in, any commercial organizations pertaining to this educational activity. Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration (FDA). Lippincott CME Institute and Ology Medical Education do not recommend the use of any agent outside of the labeled indications.Financial Support
This activity has been supported by an independent educational grant from Biogen MA. Inc. Method of Participation1. Site registration is required to begin this activity. Please click the blue "+Planner" button and follow the instructions to register.
2. Read the educational objectives, accreditation information, and faculty disclosures. 3. Take the pre-activity test. 4. View the interactive ePatient case. 5. Take the post-activity test and complete the evaluation. 6. Download certificate of CME credit.
Price:
$100.00
Credits:
- ACCME 0.5 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: SMAWEB1219_C2
Published: DECEMBER 2019
Expires: 1/1/2026
Sources:
Grant Supported
Required Passing Score: 4/5 (80%)